The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Patterns and trends in incidence, survival, and treatment among patients with early-onset lung cancer in the U.S.: A population-based study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
A team of scientists in California has tweaked the hallucinogenic drug LSD to make it usable to treat schizophrenia and other neuropsychiatric and neurodegenerative diseases. According to the ...
Sept. 4 (UPI) --A study of a pharmaceutical form of the psychedelic drug lysergic acid diethylamide suggests it might relieve anxiety symptoms for up to three months. The results of a preliminary ...
A single dose of an investigational lysergic acid diethylamide (LSD)-based medication known as MM120 (lysergide D-tartrate, Mind Medicine Inc [MindMed]) was associated with a rapid and significant ...
About The Study: In participants with moderate to severe generalized anxiety disorder, a single dose of MM120 (lysergide D-tartrate) produced a dose-dependent reduction in anxiety. Lysergide, or ...
In a recent study published in the journal Translational Psychiatry, researchers from New Zealand conducted a phase I trial to assess the effect of micro-dosing of lysergic acid diethylamide (LSD) on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback